YBX1 and myeloproliferative disorder: The expression of YBX1 was determined to be elevated in bone marrow from MPN patients (PV, ET, and myelofibrosis) compared to healthy bone marrow cells [64], suggesting cells from some MPN patients may be more sensitive to a strategy to target YBX1 function.